Predictions
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€488.40
15.06.21
15.06.21
-
15.06.22
15.06.22
-27.06%
21.05.22
21.05.22
EBIT growth >5% per year expected
Very low/no dividend yield expected
CareCloud Inc.
Start price
Target price
Perf. (%)
€7.30
12.06.21
12.06.21
€8.50
12.06.22
12.06.22
-6.16%
10.07.21
10.07.21
Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Hologic Inc.
Start price
Target price
Perf. (%)
€49.93
07.06.21
07.06.21
€55.00
07.06.22
07.06.22
42.14%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€238.80
07.06.21
07.06.21
€250.00
29.04.22
29.04.22
15.03%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€128.00
30.05.21
30.05.21
€96.00
30.05.22
30.05.22
-32.52%
20.12.21
20.12.21
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Ensign Group Inc.
Start price
Target price
Perf. (%)
€71.50
03.05.21
03.05.21
€78.00
03.05.22
03.05.22
2.80%
04.05.22
04.05.22
Could be worthwhile Investment >10% per year
Motus GI Holdings Inc.
Start price
Target price
Perf. (%)
€23.00
02.05.21
02.05.21
-
02.05.22
02.05.22
-82.60%
03.05.22
03.05.22
Could be worthwhile Investment >10% per year
Humana Inc.
Start price
Target price
Perf. (%)
€370.00
01.05.21
01.05.21
-
01.05.22
01.05.22
-5.65%
02.09.21
02.09.21
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
Centene Corp.
Start price
Target price
Perf. (%)
€51.00
01.05.21
01.05.21
€56.00
01.05.22
01.05.22
50.31%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Veeva Systems A
Start price
Target price
Perf. (%)
€233.10
01.05.21
01.05.21
€242.00
01.05.22
01.05.22
-26.31%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€266.60
29.04.21
29.04.21
€245.00
29.04.22
29.04.22
-10.43%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
MicroVision Inc
Start price
Target price
Perf. (%)
€24.88
27.04.21
27.04.21
€20.00
27.04.22
27.04.22
-24.96%
27.04.21
27.04.21
Capable Management
Probably not worthwhile Investment
Few uniques
Vivani Medical Inc.
Start price
Target price
Perf. (%)
€24.60
06.04.21
06.04.21
-
06.04.22
06.04.22
-34.15%
03.05.21
03.05.21
Good rating
Capable Management
Probably not worthwhile Investment
No Innovation
Teladoc Health Inc
Start price
Target price
Perf. (%)
€158.00
04.04.21
04.04.21
€75.00
04.04.22
04.04.22
-56.02%
05.04.22
05.04.22
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Good rating
ROE higher than 10% per year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€163.98
20.03.21
20.03.21
-
20.03.22
20.03.22
-46.87%
21.12.21
21.12.21
Could be very worthwhile Investment >20% year
Vivani Medical Inc.
Start price
Target price
Perf. (%)
€26.55
10.03.21
10.03.21
-
10.03.22
10.03.22
-86.89%
11.03.22
11.03.22
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Agilent Technologies Inc.
Start price
Target price
Perf. (%)
€101.00
09.03.21
09.03.21
€120.00
09.03.22
09.03.22
19.46%
10.03.22
10.03.22
Could be worthwhile Investment >10% per year
Vivani Medical Inc.
Start price
Target price
Perf. (%)
€24.00
08.03.21
08.03.21
€15.00
08.03.22
08.03.22
32.50%
20.03.21
20.03.21
Good rating
Capable Management
Probably not worthwhile Investment
No Innovation
Hologic Inc.
Start price
Target price
Perf. (%)
€62.50
24.02.21
24.02.21
-
24.02.22
24.02.22
1.60%
30.03.21
30.03.21
Probably not worthwhile Investment
Teleflex Inc.
Start price
Target price
Perf. (%)
€320.00
21.02.21
21.02.21
-
21.02.22
21.02.22
14.38%
23.04.21
23.04.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Dexcom Inc.
Start price
Target price
Perf. (%)
€82.24
09.02.21
09.02.21
€87.50
09.02.22
09.02.22
29.20%
12.08.21
12.08.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Sustainability is important
Higher risks for its business
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€3.44
08.02.21
08.02.21
€5.00
08.02.22
08.02.22
-27.31%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€3.12
08.02.21
08.02.21
€5.00
08.02.22
08.02.22
14.10%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€32.25
08.02.21
08.02.21
€50.00
08.02.22
08.02.22
6.98%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year